Title:
USE OF INHIBITORS OF PROGESTERONE RECEPTOR FOR TREATING CANCER
Document Type and Number:
WIPO Patent Application WO2002032429
Kind Code:
A3
Abstract:
The invention relates to the use of progesterone receptor inhibitors for inhibition of growth-factor-dependency of tumor cells.
More Like This:
| JP2018048092 | CANCER STEM CELL INHIBITOR AND USE THEREOF |
| WO/2006/054691 | SOLUBLE PROTEIN AND UTILIZATION OF THE SAME |
| JP2007522223 | Controlled release formulation |
Inventors:
LICHTNER ROSEMARIE (DE)
FUHRMANN ULRIKE (DE)
FUHRMANN ULRIKE (DE)
Application Number:
PCT/EP2001/012004
Publication Date:
February 19, 2004
Filing Date:
October 17, 2001
Export Citation:
Assignee:
SCHERING AG (DE)
LICHTNER ROSEMARIE (DE)
FUHRMANN ULRIKE (DE)
LICHTNER ROSEMARIE (DE)
FUHRMANN ULRIKE (DE)
International Classes:
A61K45/00; A61K31/138; A61K31/567; A61P35/00; C07J1/00; (IPC1-7): A61K31/56; A61P35/00
Domestic Patent References:
| WO1998034947A1 | 1998-08-13 | |||
| WO2000046234A1 | 2000-08-10 | |||
| WO1999033855A1 | 1999-07-08 |
Foreign References:
| EP0466315A2 | 1992-01-15 | |||
| US5238950A | 1993-08-24 |
Download PDF:
Previous Patent: FURTHER IMPROVEMENTS IN AND RELATING TO THE CONTROL OF COCCIDIA
Next Patent: DRUG DELIVERY SYSTEM
Next Patent: DRUG DELIVERY SYSTEM